HAPLN2 anticorps (Middle Region)
Aperçu rapide pour HAPLN2 anticorps (Middle Region) (ABIN928971)
Antigène
Voir toutes HAPLN2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- Middle Region
-
Purification
- Purified
-
Immunogène
- HAPLN2 antibody was raised in rabbit using the middle region of HAPLN2 as the immunogen
-
-
-
-
Indications d'application
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
HAPLN2 Blocking Peptide, (ABIN940243), is also available for use as a blocking control in assays to test for specificity of this HAPLN2 antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- HAPLN2 (Hyaluronan and Proteoglycan Link Protein 2 (HAPLN2))
-
Autre désignation
- HAPLN2
-
Sujet
- HAPLN2 mediates a firm binding of versican V2 to hyaluronic acid.HAPLN2 may play a pivotal role in the formation of the hyaluronan-associated matrix in the central nervous system (CNS) which facilitates neuronal conduction and general structural stabilization. HAPLN2 binds to hyaluronic acid. Synonyms: Polyclonal HAPLN2 antibody, Anti-HAPLN2 antibody, hyaluronan and proteoglycan link protein 2 antibody, BRAL1 antibody.
Antigène
-